Hint mode is switched on Switch off
For swift navigation between sections

Ondine Biomedical
LEI 9845005B69E07CGF4A56

Organization name
Ondine Biomedical Inc.
Country name
Canada
Country of registration
Canada
Industry
Medical Services
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Ondine Biomedical Inc. develops and markets topical, non-antibiotic treatments for infectious disease using photodynamic therapy as a platform technology. The Company is seeking to market a treatment for oral infectious disease. Ondine Biomedical serves customers worldwide.

Awards

Documentation

Stocks

Public debt by currencies

Codes

  • LEI
    9845005B69E07CGF4A56
  • SIC
    8731 SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
  • Business number (BN)
    892943895
Registration is required to get access.